至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance.

Blood. 2018-03; 
BhattacharjeeSouvik,CoppensIsabelle,MbengueAlassane,SureshNiraja,GhorbalMehdi,SloukaZdenek,SafeukuiInnocent,TangHsin-Yao,SpeicherDavid W,StahelinRobert V,MohandasNarla,HaldarKas
Products/Services Used Details Operation
Recombinant Proteins … Page 5. Antibodies. Pan 'PfEMP1' antibodies were raised to recombinant conserved C-terminal ATS 80 domain of PfEMP1 by the commercial vendor Genscript Inc. Anti-PI3P was from Echelon 81 Biosciences. Anti-human Band 3 was a gift from Dr. Phillip S. Low … Get A Quote

摘要

Artemisinin resistance threatens worldwide malaria control and elimination. Elevation of phosphatidylinositol-3-phosphate (PI3P) can induce resistance in blood stages of The parasite unfolded protein response (UPR) has also been implicated as a proteostatic mechanism that may diminish artemisinin-induced toxic proteopathy. How PI3P acts and its connection to the UPR remain unknown, although both are conferred by mutation in Kelch13 (K13), the marker of artemisinin resistance. Here we used cryoimmunoelectron microscopy to show that K13 concentrates at PI3P tubules/vesicles of the parasite's endoplasmic reticulum (ER) in infected red cells. K13 colocalizes and copurifies with the major virulence adhesin PfE... More

关键词